CAS 1427438-75-2

Benzonitrile, 4-bromo-2-fluoro-6-methyl-

Description:

Benzonitrile, 4-bromo-2-fluoro-6-methyl- is an organic compound characterized by its aromatic structure, which includes a benzene ring substituted with a nitrile group (–C≡N) and various halogen and methyl groups. The presence of a bromine atom at the para position, a fluorine atom at the ortho position, and a methyl group at the meta position relative to the nitrile group contributes to its unique chemical properties and reactivity. This compound is typically colorless to pale yellow and may exhibit a distinct odor. It is soluble in organic solvents and has limited solubility in water due to its hydrophobic aromatic structure. The presence of the nitrile functional group suggests potential applications in organic synthesis and as an intermediate in the production of pharmaceuticals or agrochemicals. Additionally, the halogen substituents can influence the compound's reactivity, making it a subject of interest in various chemical reactions, including nucleophilic substitutions and electrophilic aromatic substitutions. Safety precautions should be taken when handling this compound, as halogenated compounds can pose health risks.

Benzonitrile, 4-bromo-2-fluoro-6-methyl-

CAS: 1427438-75-2

Formula: C₈H₅BrFN

Purity: 98%

Color and Shape: Solid

Molecular weight: 214.0344

Ref: IN-DA009CH5

4-Bromo-2-fluoro-6-methylbenzonitrile

CAS: 1427438-75-2

4-Bromo-2-fluoro-6-methylbenzonitrile

Purity: 95%

Color and Shape: Solid

Molecular weight: 214.03g/mol

Ref: 54-PC908006

4-BROMO-2-FLUORO-6-METHYLBENZONITRILE

CAS: 1427438-75-2

Formula: C₈H₅BrFN

Purity: 98%

Color and Shape: Solid

Molecular weight: 214.037

Ref: 10-F390222

4-Bromo-2-fluoro-6-methylbenzonitrile

CAS: 1427438-75-2

4-Bromo-2-fluoro-6-methylbenzonitrile is an orally active and reversible tyrosine kinase inhibitor. It has been shown to inhibit the activity of receptor tyrosine kinases, including the epidermal growth factor receptor (EGFR). This preclinical drug may be useful in treating arthritis and other diseases that involve EGFR activation.

Formula: C₈H₅BrFN

Purity: Min. 95%

Molecular weight: 214.03 g/mol

Ref: 3D-CHC43875